MIXTARD 30 PENFILL INJECTION 100 IU/ML [SIN08200P]

Product Info

MIXTARD 30 PENFILL INJECTION 100 IU/ML

[SIN08200P]

1. What Mixtard® is and what it is used for
Mixtard® is human insulin used to treat diabetes. Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of your blood sugar. Mixtard® is a mixture of fast-acting insulin and long-acting insulin. This means that it will start to lower your blood sugar about ½ hour after you take it, and the effect will last for approximately 24 hours.

3. How to use Mixtard®
Talk about your insulin needs with your doctor and nurse. Make sure you take Mixtard® Penfill® as instructed by your doctor or nurse and follow their advice carefully.
If your doctor has switched you from one type or brand of insulin to another, your dose may have to be adjusted by your doctor.
Eat a meal or snack containing carbohydrates within 30 minutes of the injection.
It is recommended that you measure your blood sugar regularly.

How to use this insulin
Mixtard® is administered by injection under the skin (subcutaneously). Never inject your insulin directly into a vein or muscle. Always vary the sites you inject within the same region, to reduce the risk of developing lumps or skin pitting (see 5 Possible side effects – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information). The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms. Your insulin will work more quickly if you inject it around the waist.

Resuspending the insulin
Resuspending is easier when the insulin has reached room temperature.
Before you put the Penfill® cartridge into the insulin delivery system, move it up and down between positions a and b and back (see the picture) so that the glass ball moves from one end of the cartridge to the other at least 20 times. Repeat this movement at least 10 times before each injection. The movement must always be repeated until the liquid appears uniformly white and cloudy. Complete the other stages of injection without delay.

Check there are at least 12 units of insulin left in the cartridge to allow even resuspending. If there are less than 12 units left, use a new one.

How to inject this insulin

• Inject the insulin under the skin. Use the injection technique advised by your doctor or nurse and as described in your delivery system manual.

• Keep the needle under your skin for at least 6 seconds. Keep the push-button fully depressed until the needle has been withdrawn. This will ensure correct delivery and limit possible flow of blood into the needle or insulin reservoir.

• After each injection be sure to remove and discard the needle and store Mixtard® without the needle attached. Otherwise the liquid may leak out which can cause inaccurate dosing.

Do not refill Mixtard® Penfill®.
Penfill® cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine® or NovoTwist® needles.
If you are treated with Mixtard® Penfill® and another insulin Penfill® cartridge, you should use two insulin delivery systems, one for each type of insulin.

As a precautionary measure, always carry a spare insulin delivery system in case your Penfill® is lost or damaged.

2. Before you use Mixtard®

Do not use Mixtard®

• In insulin infusion pumps.

• If you are allergic (hypersensitive) to human insulin or any of the other ingredients in Mixtard® (see 7 Further information – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

• If you suspect hypoglycaemia (low blood sugar) is starting (see 4 What to do in an emergency – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

• If the cartridge or the device containing the cartridge is dropped, damaged or crushed.

• If it has not been stored correctly or been frozen (see 6 How to store Mixtard® – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

• If the resuspended insulin does not appear uniformly white and cloudy.